Äݶó°Õ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2021-2031³â) : ¼¼°è ¹× Áö¿ª Á¡À¯À², µ¿Çâ, ¼ºÀå ±âȸ ºÐ¼® ¸®Æ÷Æ® - Á¦Ç° À¯Çüº°, °ø±Þ¿øº°, ¿ëµµº°, Áö¿ªº°
Collagen Market Size and Forecast 2021-2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Source, Application, and Geography
»óǰÄÚµå : 1780304
¸®¼­Ä¡»ç : The Insight Partners
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 383 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,450 £Ü 6,272,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.
US $ 6,450 £Ü 9,091,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,450 £Ü 11,910,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Äݶó°Õ ½ÃÀå ±Ô¸ð´Â 2024³â¿¡´Â 55¾ï ´Þ·¯·Î Æò°¡µÇ¸ç, 2031³â¿¡´Â 77¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2031³â CAGRÀº 5.1%·Î ÃßÁ¤µË´Ï´Ù.

Äݶó°Õ ÃßÃâ ¹× °¡°ø ±â¼úÀÇ ¹ßÀüÀº Äݶó°Õ ±â¹Ý Á¦Ç°ÀÇ È¿À²¼º, ¼øµµ ¹× Àû¿ë °¡´É¼ºÀ» Å©°Ô º¯È­½ÃÄ×½À´Ï´Ù. ÀçÁ¶ÇÕ ±â¼ú, Á¤¹Ð ¹ßÈ¿, ÃÖÀûÈ­µÈ È¿¼Ò °¡¼öºÐÇØ µîÀÇ ±â¼ú Çõ½ÅÀ» ÅëÇØ ÀÇ·á, °Ç°­±â´É½Äǰ, È­Àåǰ µî ´Ù¾çÇÑ »ê¾÷ ºÐ¾ß¿¡ ÀûÇÕÇÑ »ýü ÀÌ¿ë·üÀÌ ³ô°í, ¸ÂÃãÇüÀ̸ç Áö¼Ó°¡´ÉÇÑ Äݶó°Õ ¼Ö·ç¼ÇÀ» °³¹ßÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 7¿ù, Â÷¼¼´ë ÀçÁ¶ÇÕ Äݶó°ÕÀÎ ¿¡º¸´Ð VECOLLANÀÌ µ¿¹°À» »ç¿ëÇÏÁö ¾Ê´Â Á¦¾îµÈ ¹Ì»ý¹° ¹ßÈ¿ °øÁ¤À» ÅëÇØ »ý»êµÇ¾ú½À´Ï´Ù. VECOLLANÀº »óó Ä¡À¯, Á¶Á÷ Àç»ý, 3D ¹ÙÀÌ¿ÀÇÁ¸°ÆÃ°ú °°Àº ÷´Ü »ý¹°ÀÇÇÐ ¿ëµµ¿¡ ÇʼöÀûÀÎ ¶Ù¾î³­ »ýüÀûÇÕ¼º°ú ¹èÄ¡ °£ Àϰü¼ºÀ» Á¦°øÇÕ´Ï´Ù. VECOLLANÀº ´Ù¾çÇÑ ÇüÅÂ¿Í °¡±³ ¿É¼ÇÀ» À§ÇØ ¼³°èµÇ¾î ±âÁ¸ÀÇ ÇüŸ¦ ³Ñ¾î Äݶó°ÕÀÇ ±â´ÉÀû °¡´É¼ºÀ» Å©°Ô ³ÐÇôÁÝ´Ï´Ù. ¸¶Âù°¡Áö·Î ÄÝÇ÷£Æ® ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö´Â À¯ÀüÀÚ Á¶ÀÛµÈ ´ã¹è ½Ä¹°À» ÀÌ¿ëÇÏ¿© ½Ä¹° À¯·¡ ÀçÁ¶ÇÕ Àΰ£ Äݶó°Õ(rhCollagen)À» °³¹ßÇß½À´Ï´Ù. ÀÌ µ¶Æ¯ÇÑ Ç÷§ÆûÀº ¸ÞµðÄà ¿¡½ºÅׯ½, Àç»ý ÀÇ·á, ¼ºÇü »ý¹° ÀÇÇп¡ ´ëÇÑ È®Àå °¡´ÉÇÏ°í ¾ÈÀüÇϸç Áö¼Ó°¡´ÉÇÑ Äݶó°Õ »ý»êÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. 3D ¹ÙÀÌ¿ÀÇÁ¸°ÆÃ ÀÓÇöõÆ® ¹× ¹Ì¿ë Á¦Ç° °³¹ß ºÐ¾ßÀÇ ¾÷°è ¸®´õµé°úÀÇ ÆÄÆ®³Ê½ÊÀº ÀÌ·¯ÇÑ Ã·´Ü Äݶó°ÕÀÇ »ó¾÷Àû, Ä¡·áÀû ÀáÀç·ÂÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù. ¼¼°è Äݶó°Õ ½ÃÀåÀº ÀÌ·¯ÇÑ Çõ½ÅÀûÀÎ ±â¼ú °³¹ß·Î ÀÎÇØ Áö¼ÓÀûÀÎ ¼ºÀåÀ» ´Þ¼ºÇϰíÀÚ ÇÕ´Ï´Ù.

°í´Ü¹é, °Ç°­ ÁöÇâÀû ½Ä»ýȰÀÇ ÀαⰡ ³ô¾ÆÁö¸é¼­ Äݶó°Õ ½ÃÀå È®´ë¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¼ÒºñÀÚµéÀº °üÀý °Ç°­, ±ÙÀ° ȸº¹ ¹× Àü¹ÝÀûÀÎ °Ç°­ À¯Áö¸¦ À§ÇØ Äݶó°ÕÀ» ÀÏ»óÀûÀÎ ¿µ¾ç º¸ÃæÁ¦·Î ¼·ÃëÇÏ´Â °æ¿ì°¡ ´Ã°í ÀÖ½À´Ï´Ù. ´Ü¹éÁúÀÌ Ç³ºÎÇÑ ½Ä½À°üÀÌ Á¡Á¡ ´õ ¸¹Àº Àα⸦ ²ø¸é¼­ Äݶó°Õ º¸ÃæÁ¦´Â ±âº»ÀûÀÎ ¿µ¾çÀ» ³Ñ¾î¼± ±â´É¼º ´Ü¹éÁú °ø±Þ¿øÀ¸·Î Àνĵǰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ä»ýȰÀÇ º¯È­´Â Äݶó°Õ ½ÃÀå¿¡¼­ÀÇ ´ë±Ô¸ð ÅõÀÚ¿Í Àü·«Àû ÀμöÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 5¿ù, º¤ÅÍ ÄÁ½´¸Ó´Â Äݶó°Õ Àü¹® ºê·£µåÀÎ µµÁî ¾Ø ÄÄÆÛ´Ï(Dose and Company)¸¦ ÀμöÇÏ¿© Á¦Ç° ¶óÀξ÷À» È®ÀåÇϰí Àüü·ÐÀû ¿µ¾ç ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼ö¿ä¸¦ Æ÷ÂøÇß½À´Ï´Ù. ¸¶Âù°¡Áö·Î 2023³â 4¿ù, ´Þ¸µÀ×±Û¸®µð¿£Ã÷´Â ºê¶óÁúÀÇ Á©¶óƾ Äݶó°Õ Á¦Á¶¾÷üÀÎ Á©³Ø½º(Gelnex)¸¦ ÀμöÇÏ¿© Äݶó°Õ °ø±Þ¸ÁÀÇ ¼¼°è È®ÀåÀ» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù. ƯÈ÷ ÇÇÆ®´Ï½º ¾ÖÈ£°¡, °í·ÉÈ­ »çȸ, °Ç°­ ÁöÇâÀûÀÎ ¹Ð·¹´Ï¾ó ¼¼´ë¸¦ Áß½ÉÀ¸·Î ´Ü¹éÁú °­È­ ±â´É¼º ½Äǰ ¹× À½·á¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. Äݶó°Õ ºÐ¸», ¹Ù, Áï¼® À½·á´Â ±ÕÇü ÀâÈù ´Ü¹éÁúÀÌ Ç³ºÎÇÑ ½Ä´Ü¿¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î Á¡Á¡ ´õ ¸¹ÀÌ ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Äݶó°ÕÀº ¼ÒÈ­¼º, »ýü ÀÌ¿ë·ü, ¾Æ¹Ì³ë»ê ÇÁ·ÎÆÄÀÏÀÌ ±ÙÀ° À¯Áö, ÇǺΠź·Â, Àå °Ç°­ µîÀÇ ¸ñÀû¿¡ ºÎÇÕÇÏ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ½À´Ï´Ù. ¼ÒºñÀÚµéÀÌ °Ç°­°ú ¶óÀÌÇÁ½ºÅ¸ÀÏÀÇ ÇÙ½É ¿ä¼Ò·Î ¿µ¾çÀ» ¿ì¼±½ÃÇÏ´Â °¡¿îµ¥, ´Ù¿ëµµÇÑ °í¼º´É ´Ü¹éÁú·Î¼­ Äݶó°ÕÀÇ ¿ªÇÒÀº ´õ¿í °­È­µÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Äݶó°ÕÀÌ ÀÏ»óÀûÀÎ ½Ä»ýȰ¿¡ µµÀԵǸ鼭 »õ·Î¿î Á¦Ç° Çõ½ÅÀÌ ÀϾ°í, ½Äǰ, À½·á, °Ç°­º¸Á¶½Äǰ µî ´Ù¾çÇÑ ºÐ¾ß¿¡¼­ Äݶó°ÕÀÇ ¿ëµµ°¡ È®´ëµÇ¸é¼­ Äݶó°Õ ½ÃÀåÀÇ ÅºÅºÇÑ ¹Ì·¡°¡ Çü¼ºµÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¿ëµµ¿¡ µû¶ó Äݶó°Õ ½ÃÀåÀº ½Äǰ ¹× À½·á, ÀǾàǰ ¹× ¿µ¾ç º¸ÃæÁ¦, ÆÛ½º³ÎÄÉ¾î ¹× È­Àåǰ, µ¿¹° ¿µ¾ç, ÇコÄÉ¾î ¹× ±âŸ·Î ºÐ·ùµË´Ï´Ù. 2024³â Äݶó°Õ ½ÃÀå¿¡¼­´Â ÀǾàǰ°ú °Ç°­±â´É½ÄǰÀÌ Å« ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Äݶó°ÕÀº ÇǺÎ, ¸ð¹ß, ¼ÕÅéÀÇ °Ç°­À» ÃËÁøÇϰí, ±ÙÀ°ÀÇ ¼ºÀå°ú ȸº¹À» °³¼±Çϸç, °üÀý°ú »À¸¦ ÁöÁöÇÏ´Â ÀǾàǰ°ú °Ç°­ º¸Á¶ ½Äǰ¿¡ »ç¿ëµË´Ï´Ù. Äݶó°ÕÀº ¿¬°ñ Àç»ýÀ» ÃËÁøÇÏ°í °üÀýÀÇ ÅëÁõ°ú ¿°ÁõÀ» ¾ïÁ¦ÇÏ¸ç °üÀý ±â´ÉÀ» °³¼±ÇÕ´Ï´Ù. Äݶó°ÕÀº »À¸¦ ưưÇÏ°Ô ÇÏ°í °üÀý ÅëÁõÀ» ¿ÏÈ­ÇÏ´Â µ¥ µµ¿òÀÌ µÇ´Â °Ç°­ º¸Á¶ ½Äǰ¿¡ »ç¿ëµË´Ï´Ù.

Äݶó°Õ ½ÃÀå¿¡ Âü¿©Çϰí ÀÖ´Â ±â¾÷¿¡´Â GELITA AG, Rousselot BV, Titan Biotech Ltd, Tessenderlo Group NV, Ewald-Gelatine GmbH, BioCell Technology LLC, Lapi Gelatine SpA, Weishardt Holding SA, Nippi Collagen NA Inc, Nitta Gelatin India Ltd, Darling Ingredients Inc µîÀÌ ÀÖ½À´Ï´Ù. Äݶó°Õ ½ÃÀå¿¡¼­ »ç¾÷À» ¿î¿µÇÏ´Â ±â¾÷Àº °í°´ ¼ö¿ä¸¦ ÃæÁ·½Ã۱â À§ÇØ Çõ½ÅÀûÀÎ Á¦Ç°À» ÇÕ¸®ÀûÀÎ °¡°Ý¿¡ Á¦°øÇÏ´Â µ¥ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù.

Àüü Äݶó°Õ ½ÃÀå ±Ô¸ð´Â 1Â÷ Á¤º¸¿Í 2Â÷ Á¤º¸¸¦ ¸ðµÎ »ç¿ëÇÏ¿© °è»êµË´Ï´Ù. ½ÃÀå°ú °ü·ÃµÈ ÁúÀû, ¾çÀû Á¤º¸¸¦ ¾ò±â À§ÇØ »ç³»¿ÜÀÇ ´Ù¾çÇÑ Á¤º¸¿øÀ» ÅëÇØ öÀúÇÑ 2Â÷ Á¶»ç¸¦ ½Ç½ÃÇß½À´Ï´Ù. ¶ÇÇÑ µ¥ÀÌÅ͸¦ °ËÁõÇϰí ÁÖÁ¦¿¡ ´ëÇÑ º¸´Ù ºÐ¼®ÀûÀÎ ÀλçÀÌÆ®¸¦ ¾ò±â À§ÇØ ¾÷°è °ü°èÀÚµé°ú ¿©·¯ Â÷·ÊÀÇ 1Â÷ ÀÎÅͺ並 ÁøÇàÇß½À´Ï´Ù. ÀÌ Á¶»ç °úÁ¤¿¡´Â ºÎ»çÀå, ½ÃÀå °³¹ß ¸Å´ÏÀú, ½ÃÀå ÀÎÅÚ¸®Àü½º ¸Å´ÏÀú, ±¹³» ¿µ¾÷ ¸Å´ÏÀú µî ¾÷°è Àü¹®°¡¿Í Äݶó°Õ ½ÃÀå Àü¹® ¹ë·ù¿¡ÀÌ¼Ç Àü¹®°¡, ¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®, Ű ¿ÀÇǴϾ𠸮´õ µî ¿ÜºÎ ÄÁ¼³ÅÏÆ®°¡ Âü¿©Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå °³¿ä

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå Äݶó°Õ ½ÃÀå ±¸µµ

Á¦5Àå Äݶó°Õ ½ÃÀå : ÁÖ¿ä ½ÃÀå ¿ªÇÐ

Á¦6Àå Äݶó°Õ ½ÃÀå : ¼¼°è ½ÃÀå ºÐ¼®

Á¦7Àå Äݶó°Õ ½ÃÀåÀÇ Á¦Ç° À¯Çüº° ¼ö·®¡¤¸ÅÃ⠺м®

Á¦8Àå Äݶó°Õ ½ÃÀåÀÇ °ø±Þ¿øº° ¼ö·®¡¤¸ÅÃ⠺м®

Á¦9Àå Äݶó°Õ ½ÃÀåÀÇ ¿ëµµº° ¼ö·®¡¤¸ÅÃ⠺м®

Á¦10Àå Äݶó°Õ ½ÃÀå : Áö¿ªº° ½ÃÀå ºÐ¼®

Á¦11Àå °æÀï ±¸µµ

Á¦12Àå Äݶó°Õ ¾÷°è »óȲ

Á¦13Àå ±â¾÷ °³¿ä

Á¦14Àå ºÎ·Ï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The collagen market size is valued at US$ 5.50 billion in 2024 and is projected to reach US$ 7.76 billion by 2031; it is estimated to register a CAGR of 5.1% from 2025 to 2031.

Technological advancements in collagen extraction and processing have significantly transformed collagen-based products' efficiency, purity, and application potential. Innovations such as recombinant technology, precision fermentation, and optimized enzymatic hydrolysis have enabled the development of highly bioavailable, customizable, and sustainable collagen solutions tailored to a wide range of industries, including medical, nutraceuticals, and cosmetics. For instance, in July 2024, Evonik VECOLLAN, a next-generation recombinant collagen, was produced through a controlled, animal-free microbial fermentation process. It offers exceptional biocompatibility and batch-to-batch consistency, critical for advanced biomedical applications such as wound healing, tissue regeneration, and 3D bioprinting. VECOLLAN is engineered for diverse forms and cross-linking options, significantly expanding the functional potential of collagen beyond traditional formats. Similarly, CollPlant Biotechnologies has developed plant-based recombinant human collagen (rhCollagen) using genetically engineered tobacco plants. This unique platform allows for scalable, safe, and sustainable collagen production for medical aesthetics, regenerative medicine, and orthobiologics. CollPlant's partnerships with industry leaders to develop 3D bioprinted implants and aesthetic products underscore these advanced collagen forms' commercial and therapeutic viability. The global collagen market is poised for sustained growth driven by these transformative technological developments.

The growing popularity of high-protein and health-conscious diets significantly contributes to the expansion of the collagen market. Consumers increasingly integrate collagen into their daily nutritional regimes to support joint health, muscle recovery, and overall well-being. As protein-rich diets gain momentum, collagen supplements are recognized as a functional protein source, offering additional benefits beyond basic nutrition. This dietary shift has driven major investment and strategic acquisitions in the collagen market. For example, in May 2024, Vector Consumer acquired Dose & Co, a collagen-focused brand, to expand its product offerings and capitalize on consumer demand for holistic nutrition solutions. Similarly, in April 2023, Darling Ingredients acquired Gelnex, a Brazilian gelatin and collagen producer, to secure a larger global collagen supply chain footprint. The demand for protein-enhanced functional foods and beverages is surging, especially among fitness enthusiasts, aging populations, and health-conscious millennials. Collagen powder, bars, and ready-to-drink beverages are increasingly positioned as essential elements of a balanced, protein-rich diet. Moreover, collagen is gaining traction for its digestibility, bioavailability, and amino acid profile, which align well with the goal of muscle maintenance, skin elasticity, and gut health. As consumers continue to prioritize nutrition as a pillar of health and lifestyle, the role of collagen as a versatile, high-performance protein is expected to strengthen further. The rising incorporation of collagen in everyday diets is poised to unlock new product innovation and broaden its applications across the food, beverages, and dietary supplements sectors, shaping a robust future for the collagen market.

Based on the applications, the collagen market is segmented into food and beverages, pharmaceuticals and nutraceuticals, personal care and cosmetics, animal nutrition, healthcare, and others. Pharmaceuticals and nutraceuticals held a large share of the collagen market in 2024. Collagen is used in pharmaceutical drugs and dietary supplements that boost skin, hair, and nail health, improve muscle growth and recovery, and provide joint and bone support. It stimulates cartilage regeneration, reducing joint pain and inflammation, and improving joint function. Collagen is used in supplements formulated to make bones strong and provide relief from joint pain.

Some of the players operating in the collagen market include GELITA AG, Rousselot BV, Titan Biotech Ltd, Tessenderlo Group NV, Ewald-Gelatine GmbH, BioCell Technology LLC, Lapi Gelatine SpA, Weishardt Holding SA, Nippi Collagen NA Inc, Nitta Gelatin India Ltd, and Darling Ingredients Inc, and others. Players operating in the collagen market focus on providing innovative products at affordable prices to fulfill customer demand.

The overall collagen market size has been derived using both primary and secondary sources. To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market. Also, multiple primary interviews have been conducted with industry participants to validate the data and gain more analytical insights into the topic. The participants of this process include industry experts such as VPs, business development managers, market intelligence managers, and national sales managers-along with external consultants such as valuation experts, research analysts, and key opinion leaders-specializing in the collagen market.

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Collagen Market Landscape

5. Collagen Market - Key Market Dynamics

6. Collagen Market - Global Market Analysis

7. Collagen Market Volume and Revenue Analysis - by Product Type

8. Collagen Market Volume and Revenue Analysis - by Source

9. Collagen Market Volume and Revenue Analysis - by Application

10. Collagen Market - Geographical Analysis

11. Competitive Landscape

12. Collagen Industry Landscape

13. Company Profiles

14. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â